US group transfers pharmaceutical production technology to Vietnam
US-based Pfizer Group, one of the world's premier biopharmaceutical companies, has signed an agreement on the transfer of pharmaceutical production technology to Vietnamese enterprises, so first products are scheduled to be produced in 2020.
National Assembly Vice Chairman Phung Quoc Hien (R) receives Pfizer Group's Regional President for Asia and Emerging Markets Pierre Gaudreault (Source: VNA)
Hanoi (VNA) – US-based Pfizer Group, one of the world's premierbiopharmaceutical companies, has signed an agreement on the transfer ofpharmaceutical production technology to Vietnamese enterprises, so firstproducts are scheduled to be produced in 2020.
The information wasmade by the group’s Regional President for Asia and Emerging Markets PierreGaudreault in a meeting with Vietnam’s National Assembly Vice Chairman PhungQuoc Hien in Hanoi on January 10.
Pierre Gaudreaultaffirmed that the signing of the deal shows Pfizer’s commitment to long-terminvestment in Vietnam, thus contributing to the country’s pharmaceuticalindustry and applying technology with international standard in its drugproduction.
According to him, thegroup decided to invest in Vietnam as it sees potential of the Vietnamesemarket and its surrounding areas as well as the country’s open investmentpolicies.
He pledged to sharethe group’s best experiences with Vietnamese enterprises, while hoping that theVietnamese Government will continue creating conditions on policies andprocedures for the group to expand its presence in the country.
NA Vice Chairman PhungQuoc Hien stated that the transfer of technology is a breakthrough in the twosides’ cooperation. This not only is a good chance for Vietnam’s pharmaceuticalproducers to improve their capacity, but also helps Vietnamese people buyhigh-quality drugs at reasonable prices.
He suggested Pfizerstudy Vietnam’s climate to produce types of drugs that are suitable toVietnamese and Southeast Asian markets.
He affirmed thatVietnam will facilitate investment of foreign enterprises, includingPfizer.-VNA
Prime Minister Nguyen Xuan Phuc chaired a seminar on investment attraction to Vietnam in the context of the Fourth Industrial Revolution with more than 40 leading businesses of the US in New York city on September 27.
Prime Minister Nguyen Xuan Phuc on November 17 hosted a reception for representatives of several prestigious US companies on the occasion of his attendance at the 26th APEC Economic Leaders’ Meeting in Port Moresby, Papua New Guinea.
Ho Chi Minh City hopes to receive support and cooperation from foreign partners, including the US, in building its smart transport system, said a city senior official.
The Hue Monuments Conservation Centre is partnering with US Seagate and CyArk companies to digitalise data of two heritages of TuDuc Tomb and An Dinh Palace, Director of the centre Phan Thanh Hai said on January 9.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
National Assembly Vice Chairman Phung Quoc Hien (R) receives Pfizer Group's Regional President for Asia and Emerging Markets Pierre Gaudreault (Source: VNA) 
